A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BG-75202, Alone and in Combination with Other Agents, in Patients with Myeloid Malignancies

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2026
This article has no abstract
Epistemonikos ID: 7b67549a05c47b514e455f4c9cc2b3dc24239566
First added on: Oct 22, 2026